MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 28, Issue 14, Pages 1957-1965
Publisher
Wiley
Online
2013-10-12
DOI
10.1002/mds.25646
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease
- (2013) Juliet M. Taylor et al. NEUROCHEMISTRY INTERNATIONAL
- Epitope-tagged dopamine transporter knock-in mice reveal rapid endocytic trafficking and filopodia targeting of the transporter in dopaminergic axons
- (2012) Anjali Rao et al. FASEB JOURNAL
- Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility
- (2012) Lucia Frau et al. JOURNAL OF NEUROCHEMISTRY
- Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs
- (2011) Russell C. Callaghan et al. DRUG AND ALCOHOL DEPENDENCE
- Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease
- (2011) Hui-Ming Gao et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Glia: Initiators and progressors of pathology in Parkinson's disease
- (2011) Glenda M. Halliday et al. MOVEMENT DISORDERS
- Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA
- (2011) Noelia Granado et al. NEUROBIOLOGY OF DISEASE
- Neurodegeneration and Inflammation in Parkinson's disease
- (2011) Sudarshan Phani et al. PARKINSONISM & RELATED DISORDERS
- Neuroinflammation in Parkinson's disease
- (2011) Etienne C. Hirsch et al. PARKINSONISM & RELATED DISORDERS
- IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease
- (2011) C Barcia et al. Cell Death & Disease
- Cytochrome P450 2D6 enzyme neuroprotects against 1-methyl-4-phenylpyridinium toxicity in SH-SY5Y neuronal cells
- (2010) Amandeep Mann et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Dopamine-Dependent Tuning of Striatal Inhibitory Synaptogenesis
- (2010) D. Goffin et al. JOURNAL OF NEUROSCIENCE
- Substance abuse and movement disorders
- (2010) John C.M. Brust MOVEMENT DISORDERS
- Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders
- (2010) Russell C. Callaghan et al. MOVEMENT DISORDERS
- Parkinsonism in patients with a history of amphetamine exposure
- (2010) Chadwick W. Christine et al. MOVEMENT DISORDERS
- Missing pieces in the Parkinson's disease puzzle
- (2010) Jose A Obeso et al. NATURE MEDICINE
- Neuroprotective and anti-inflammatory effects of the adenosine A2A receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease
- (2010) Lucia Frau et al. SYNAPSE
- Parkinson's Disease and Residential Exposure to Maneb and Paraquat From Agricultural Applications in the Central Valley of California
- (2009) S. Costello et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Caffeine Enhances Astroglia and Microglia Reactivity Induced by 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) in Mouse Brain
- (2009) Amit Khairnar et al. NEUROTOXICITY RESEARCH
- Chronic activation of the D2 dopamine autoreceptor inhibits synaptogenesis in mesencephalic dopaminergic neuronsin vitro
- (2008) C. Fasano et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The Consequences of 3,4-Methylenedioxymethamphetamine Induced CYP2D6 Inhibition in Humans
- (2008) Brian O'Mathúna et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Do early-life insults contribute to the late-life development of Parkinson and Alzheimer diseases?
- (2008) Diane B. Miller et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Neuro-immune crosstalk in CNS diseases
- (2008) M. Kerschensteiner et al. NEUROSCIENCE
- Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine
- (2007) C. Chipana et al. NEUROCHEMISTRY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started